Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Hair or fiber wrapped tightly around a toe can lead to serious injury if not treated quickly.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

TTD hair brittleness is caused by multiple structural abnormalities.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Topical tofacitinib may help regrow hair in children with alopecia totalis.